Kerala

AOC

Goods

Medicines

e-tender for the procurement of rare disease for the year 2025-26

Kerala Medical Services Corporation Ltd

Thiruvananthapuram, Kerala

Amount: Refer DocsCloses: 20 Nov 2025Closed

Timeline

Published6 Nov 2025
Closed20 Nov 2025
Technical Evaluation8 Dec 2025
Awarded6 Jun 2026

Bids

Item Wise

2 Bids6 Jun 2026

#	Company	Amount	Rank	Status
1	Pfizer Products India Pvt. Ltd. L1₹1.6 CrAccepted-AOC THE CAPITAL 1802 1901 PLOT NO C 70 G BLOCK BANDRA KURLA COMPLEX BANDRA EAST MUMBAI MAHARASHTRA INDIA 400051 \| MUMBAI \| MUMBAI \| MAHARASHTRA \| 400051	₹1.6 Cr Quoted ₹1 L	L1	Accepted-AOC DETAILS IN NOTICE
2	Novo Nordisk India Private Limited NO L1Rejected-AOC 1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 \| BANGALORE \| BANGALORE \| KARNATAKA \| 560045	-	NO L1	Rejected-AOC DETAILS IN NOTICE

BoQ Comparative

Line Items (1)

Sl No	Description	Qty	Unit	Novo Nordisk India Private Limited L2	Pfizer Products India Pvt. Ltd. L1
1.00	RECOMBINANT HUMAN GROWTH HORMONE for injection [Injectable pen with the needle] • Recombinant growth hormone for daily injection • Ready to use pen for subcutaneous injection • Liquid/powder with reconstitution • Needle for subcutaneous injection should be with the pen free of cost (minimum one needle per mg) (5mg pen with 5 needles) • Should be available in different strengths • Should be approved for GH deficiency, Turner syndrome, Noonan syndrome and prader willi syndrome by the government and international agencies.	72,000	Pen	12,455 ₹13,077.75	218.06 ₹228.96 Lowest

Tender Value

Refer Docs

EMD Value

₹50,000

Closing Date

20 Nov 2025, 5:00 pmClosed

Tender Inviting Organisation

Name

Managing Director

Address

KMSCL, THYCAUD

Work Description

e-tender for the procurement of rare disease for the year 2025-26

Tender Information

Tender ID

2025_KMSCL_819606_1

Reference Number

KMSCL/ED/RD-SAT/RC/2025/026

Tender Type

Open Tender

Product Category

Medicines

Form of Contract

Item Wise

Period of Work

365 days

Location

Thiruvananthapuram

Source Website

Subscribe to view

Eligibility / Pre-Qualification

please refer tender document

Documents Required

20 documents required · 20 mandatory

Fee/PreQual/Technical

RequiredCheck list in Anx 1 (.pdf)

RequiredThe details of offline EMD submitted as per the sl no 2 of Anx 1 (.pdf)

RequiredBid offer form as per sl no 3 of Anx 1 (.pdf)

RequiredNotary attested copy of Annual Turnover stmt as per sl no 4 of Anx 1 (.pdf)

RequiredNotary attested copy of original manufacturing license as per sl no. 5 of Anx 1 (.pdf)

RequiredNotary attested copy of valid import license as per sl no 6 of Anx 1 (.pdf)

RequiredNotary attested copies product wise market standing certificate as per sl no 7 of Anx 1 (.pdf)

RequiredNotary attested copy of valid license for the sale of drugs as per sl no 8 of Anx1 (.pdf)

RequiredNotary attested copy of valid WHO-GMP certificate as per sl no 9 of Anx 1 (.pdf)

RequiredNotary attested copy of COPP issued by the licensing autority as per sl no 10 of Anx 1 (.pdf)

RequiredNotary attested copy of approval from USFDA as per sl no 11 of Anx 1 (.pdf)

RequiredNotary attested copy of current Non conviction certificate as per sl no 12 of Anx 1 (.pdf)

RequiredNotary attested performance statement as per sl no 13 of Anx 1 (.pdf)

RequiredNotary attested copy Power of Attorney as per sl no 14 of Anx 1 (.pdf)

RequiredNotary attested copy of undertaking as per sl no 15 of Anx 1 (.pdf)

RequiredNotary attested copy of Declaration and undertaking as per sl no 16 of Anx 1 (.pdf)

RequiredThe bidder shall furnish the notarized copies of details of supply as per sl no 17 of Anx 1 (.pdf)

RequiredNotary attested copy of Audited Balance sheets and P and L stmt as per sl no 18 of Anx 1 (.pdf)

RequiredNotary attested details of the bidders and manufacturing units as per sl no 19 of Anx 1 (.pdf)

Finance

RequiredPrice bid format (.xls)

Fee & Financial Details

Tender Fee Amount

₹29,500

Tender Fee Exemption Allowed

Yes

EMD Fee Amount

₹50,000

EMD Fee Exemption Allowed

Yes

Important Dates

Last Activity

6 Jun 2026

Published

6 Nov 2025

Bid Opening

22 Nov 2025

Download Starts

6 Nov 2025

Download Ends

20 Nov 2025

Submission Starts

6 Nov 2025

Clarification Period

6 Nov 2025 - 20 Nov 2025

Stage Documents

Stage Summary Snapshot

stage.html

html • 0.04 MB

Technical Evaluation

tech_eval.pdf

PDF

Financial Bid Opening

boq_comp_chart.xlsx

xlsx

Financial Evaluation

fin_eval.pdf

PDF

Award of Contract

aoc.pdf

PDF

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Page Snapshot

details.html

html • 0.04 MB

NIT Documents

Tendernotice_1.pdf

PDF • 0.36 MB

Work Item Documents

tender.pdf

Tender Documents • 1.82 MB

BOQ_1374004.xls

BOQ • 0.29 MB

Ready to Participate?

Download all tender documents and submit your bid

Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .

Loading…

Company

Pfizer Products India Pvt. Ltd.

L1₹1.6 CrAccepted-AOC

THE CAPITAL 1802 1901 PLOT NO C 70 G BLOCK BANDRA KURLA COMPLEX BANDRA EAST MUMBAI MAHARASHTRA INDIA 400051 | MUMBAI | MUMBAI | MAHARASHTRA | 400051

Novo Nordisk India Private Limited

NO L1Rejected-AOC

1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 | BANGALORE | BANGALORE | KARNATAKA | 560045

Sl No

Description

Qty

Unit

Novo Nordisk India Private Limited

Pfizer Products India Pvt. Ltd.

1.00

RECOMBINANT HUMAN GROWTH HORMONE for injection [Injectable pen with the needle] • Recombinant growth hormone for daily injection • Ready to use pen for subcutaneous injection • Liquid/powder with reconstitution • Needle for subcutaneous injection should be with the pen free of cost (minimum one needle per mg) (5mg pen with 5 needles) • Should be available in different strengths • Should be approved for GH deficiency, Turner syndrome, Noonan syndrome and prader willi syndrome by the government and international agencies.

72,000

Pen

12,455

₹13,077.75

218.06

₹228.96

Lowest